Showing results (81-90 of 98) with videos related to
Sort By:
Pageof 10
Pharmacological Research|September 10, 2021
Unraveling binding mechanism and kinetics of macrocyclic Gα<sub>q</sub> protein inhibitorsJan H Voss, Jessica Nagel, Muhammad Rafehi, et al.Pharmaceutics|March 28, 2024
Mesoporous Silica as an Alternative Vehicle to Overcome Solubility LimitationsTim Becker, Jan Heitkötter, Anna K Krome, et al.Pharmaceutics|January 21, 2023
Imaging of Gα<sub>q</sub> Proteins in Mouse and Human Organs and TissuesJan H Voss, Haneen Al-Hroub, Robin Gedschold, et al.Chemmedchem|June 7, 2018
Deciphering Specificity Determinants for FR900359-Derived G<sub>q</sub> α Inhibitors Based on Computational and Structure-Activity StudiesRaphael Reher, Toni Kühl, Suvi Annala, et al.The Journal of Biological Chemistry|February 27, 2021
An experimental strategy to probe Gq contribution to signal transduction in living cellsJulian Patt, Judith Alenfelder, Eva Marie Pfeil, et al.Pharmaceutics|January 21, 2023
Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant <i>Staphylococcus aureus</i>Katharina Rox, Tim Becker, Andrea Schiefer, et al.Journal of Natural Products|July 1, 2021
Feature-Based Molecular Networking for the Targeted Identification of G<sub>q</sub>-Inhibiting FR900359 DerivativesWiebke Hanke, Julian Patt, Judith Alenfelder, et al.Pharmaceutics|August 26, 2022
In Vitro-In Vivo Relationship in Mini-Scale-Enabling Formulations of Corallopyronin ATim Becker, Anna K Krome, Sahel Vahdati, et al.Nature Communications|January 9, 2021
Thioesterase-mediated side chain transesterification generates potent Gq signaling inhibitor FR900359Cornelia Hermes, René Richarz, Daniel A Wirtz, et al.Natural Product Reports|June 22, 2022
Corallopyronin A: antimicrobial discovery to preclinical developmentAnna K Krome, Tim Becker, Stefan Kehraus, et al.Pageof 10